HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

T 1095

inhibits sodium-glucose cotransporters; structure in first source
Also Known As:
T-1095; 3-(Benzo(b)furan-5-yl)-2', 6'-dihydroxy-4'-methylpropiophenone-2'-O-(6-O-methoxycarbonyl)-beta-D- glucopyranoside
Networked: 11 relevant articles (6 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Oku, A: 8 articles (04/2002 - 03/2000)
2. Ueta, K: 7 articles (05/2001 - 03/2000)
3. Saito, A: 7 articles (05/2001 - 03/2000)
4. Arakawa, K: 6 articles (05/2001 - 03/2000)
5. Tsuda, K: 4 articles (04/2002 - 08/2000)
6. Adachi, T: 4 articles (04/2002 - 08/2000)
7. Yasuda, K: 4 articles (04/2002 - 08/2000)
8. Nawano, M: 4 articles (05/2001 - 03/2000)
9. Kano-Ishihara, T: 4 articles (05/2001 - 03/2000)
10. Anai, M: 3 articles (05/2001 - 03/2000)

Related Diseases

1. Hyperglycemia
2. Glucose Intolerance
3. Diabetic Neuropathies (Diabetic Neuropathy)
4. Insulin Resistance
5. Diabetes Mellitus

Related Drugs and Biologics

1. Glucose (Dextrose)
2. Blood Glucose (Blood Sugar)
3. Gur
4. Insulin (Novolin)
5. Facilitative Glucose Transport Proteins (Glucose Transporter)
6. Streptozocin (Streptozotocin)
7. Sodium
8. benzofuran

Related Therapies and Procedures

1. Oral Administration